Peptide Early Discovery Services
Peptide drugs, composed of short chains of amino acids, represent a promising class of therapeutics with unique advantages over traditional small-molecule drugs.
WuXi AppTec provides multiple approaches to discover peptide hits, including DNA-Encoded Library (DEL) and display technologies. Peptide DELs are synthesized through chemical reactions, while display technologies utilize biological synthesis. The combination of DEL and display technologies enables researchers to explore vast chemical space.
Additionally, we provide off-the-shelf and highly customizable peptide libraries, as well as broad availability of unnatural amino acids. Our comprehensive bioassay platform is well-suited for peptide profiling and hit-to-lead optimization. WuXi AppTec specialists offer advanced peptide conjugation, modeling, and synthesis services.
To learn more about our peptide drug discovery & development services, click HERE
Flyer_Peptide Early Discovery Services
Related Content
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
VIEW RESOURCEOligonucleotide therapeutics represent a transformative treatment modality with demonstrated potential across metabolic disorders, CNS diseases, muscular dystrophies, and a broad...
VIEW RESOURCE